Global CBD API Market growth is valued at US$ 521.94 Mn in 2024 and is expected to reach US$ 2233.37 Mn by 2034, with a CAGR of 15.8% during the forecast period of 2025-2034. Key Industry Insights & Findings from the report: CBD has been recommended for a range of health conditions, it is considered the best treatment while considering the worst childhood epilepsy disorders. The increasing demand for health and wellne...
Report ID: 1478 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global RNA-based Therapeutics Market is valued at USD 12.4 Bn in 2024 and is predicted to reach USD 22.6 Bn by the year 2034 at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing biopharmaceutical sector, characterized by increased investment and interest in innovative therapies, is propelling the RNA-based therapeutics market. The entry of new biotech startups focused on R...
Report ID: 1151 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 185
Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remarkably promising treatment for a different types of cancer patients. The approval of CAR-T cell therapy products represents one of the most significant breakthroughs in cancer since the introduction of ...
Report ID: 1083 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
The Multi Cancer Early Detection Market Size is valued at 1.20 Billion in 2024 and is predicted to reach 5.60 Billion by the year 2034 at a 16.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing cases of various types of cancer globally is driving the demand for early detection methods. Government initiatives and funding to support cancer r...
Report ID: 1408 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 185
GLP-1 Agonists Market Size is valued at USD 43.1 Bn in 2024 and is predicted to reach USD 260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034. GLP-1 agonists, known to be beneficial in treating type 2 diabetes, are glucagon-like peptide-1 receptor agonists. The action of GLP-1 RAs is to enhance insulin synthesis and inhibit glucagon secretion by activating GLP-1 receptors. While all GLP-1 RAs have the ...
Report ID: 2289 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global Regenerative Aesthetics Exosome Products Market Size is valued at USD 81.1 Million in 2024 and is predicted to reach USD 1689.7 Million by the year 2034 at a 35.9% CAGR during the forecast period for 2025-2034. Regenerative aesthetics exosome products represent a cutting-edge advancement in skin rejuvenation and hair restoration, offering a minimally invasive approach. These nano-sized extracellular vesicles derived from stem cells cont...
Report ID: 2555 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 177
Cannabinoid Derived Pharmaceutical Market Size is valued at USD 12.6 Billion in 2024 and is predicted to reach USD 81.1 Billion by the year 2034 at an 20.8% CAGR during the forecast period for 2025-2034. Cannabinoids are naturally occurring compounds derived from the Cannabis sativa plant. In recent years, Cannabinoids/medical marijuana have witnessed increased attention due to its growing therapeutic applications in human medicine. ...
Report ID: 1042 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global Nucleic Acid Therapeutics CDMO Market Size is valued at USD 2,540.9 Million in 2024 and is predicted to reach USD 8,688.2 Million by the year 2034 at an 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: A robust pipeline of nucleic acid-based drugs and high levels of investment from pharmaceutical companies and venture capitalists are boosting the market. The development of nove...
Report ID: 1348 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 185
Global GMP Plasmid DNA Manufacturing Market Size is valued at USD 212.1 Million in 2024 and is predicted to reach USD 512.1 Million by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Modern medicine heavily relies on plasmid DNA (PDNA). Plasmid DNA can be utilized either explicitly for a variety of therapeutic purposes, including gene therapy and the production of vaccine antigens, or indirectly for a broad range of rese...
Report ID: 1437 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Global Mitochondrial-Based Therapeutics Market Size is valued at USD 388.2 Mn in 2023 and is predicted to reach USD 682.7 Mn by the year 2031 at a 7.5% CAGR during the forecast period for 2024 to 2031. Mitochondrial-Based Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication, By Route of Administration, By Distribution Channel...
Report ID: 2884 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 172
Pharmaceuticals